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A B S T R A C T
Questions: In people with chronic obstructive pulmonary disease (COPD), are activity phenotypes (based
on physical activity and recreational screen time) associated with mortality and cardiometabolic risk
factors? Design: Cohort study. Participants: People with COPD aged  40 years and who were current or
ex-smokers were identified from the 2003 Scottish Health Survey. Outcome measures: Data were
collected regarding demographics, anthropometric measurements, medical history, physical activity,
sedentary behaviour, health outcomes, and mortality. Analysis: Participants were categorised into one of
the following activity phenotypes: ‘couch potatoes’ were those who were insufficiently active with high
leisure-based sitting time and/or no domestic physical activity; ‘light movers’ were insufficiently active
with some domestic physical activity; ‘sedentary exercisers’ were sufficiently active with high leisure-
based sitting time; and ‘busy bees’ were sufficiently active with low leisure-based sitting time.
‘Sufficiently active’ was defined as adhering to physical activity (PA) recommendations of  7.5 metabolic
equivalent (MET) hours/week. ‘Low leisure-based sitting time’ was defined as  200 minutes of
recreational screen time/day. Results: The 584 participants had a mean age of 64 years (SD 12) and 52%
were male. Over 5.5 years (SD 1.3) of follow-up, there were 81 all-cause deaths from 433 COPD
participants with available data. Compared to the ‘couch potatoes’, there was a reduced risk of all-cause
mortality in the ‘busy bees’ (Hazard Ratio 0.26, 95% CI 0.11 to 0.65) with a trend towards a reduction in
mortality risk in the other phenotypes. The odds of diabetes were lower in the ‘busy bees’ compared to
the ‘couch potatoes’ (OR 0.14, 95% CI 0.03 to 0.67). Conclusions: Adhering to physical activity guidelines
and keeping leisure-based sitting time low had a mortality benefit and lowered the odds of diabetes in
people with COPD. [McKeough Z, Cheng SWM, Alison J, Jenkins C, Hamer M, Stamatakis E (2018) Low
leisure-based sitting time and being physically active were associated with reduced odds of death
and diabetes in people with chronic obstructive pulmonary disease: a cohort study. Journal of
Physiotherapy 64: 114–120]
© 2018 Published by Elsevier B.V. on behalf of Australian Physiotherapy Association. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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In the general population and in the area of chronic disease, two
distinct fields of research have developed to examine the impact of
activity behaviours on health outcomes: physical activity (PA)
research and sedentary behaviour (SB) research. Historically, PA
research emerged first and examined behaviours described across
a PA continuum based on intensity level from engagement in light,
moderate, vigorous and very vigorous activity. This area of research
has resulted in PA guidelines being developed. The aerobic
component of these guidelines suggests that adults should have
a minimum engagement of 150 minutes of moderate-intensity
activity or 75 minutes of vigorous activity or an equivalent
combination of both per week to prevent deterioration inhttps://doi.org/10.1016/j.jphys.2018.02.007
1836-9553/© 2018 Published by Elsevier B.V. on behalf of Australian Physiotherapy A
creativecommons.org/licenses/by-nc-nd/4.0/).health.1,2 By definition, physical inactivity now refers to not
meeting the activity guidelines. This terminology around physical
inactivity is distinct from the field of research on SB, which has
been defined as engagement in activities at a low intensity
of < 1.5 metabolic equivalents (METs) in a sitting or lying posture
but not including sleep. This emerging field of research developed
from the evidence that a large proportion of the healthy population
engage in SB3 and that it is an independent predictor of poor health
outcomes.4,5
The extent of information in these two fields of research for
chronic respiratory disease was recently reviewed6 by examining
clinical practice guidelines. While there are recommendations to
guide clinicians about engagement in PA for people with chronic
obstructive pulmonary disease (COPD) by following the general
adult PA guidelines, there are no such recommendations for SB.6ssociation. This is an open access article under the CC BY-NC-ND license (http://
Research 115Furthermore, several studies have indicated that people with COPD
engage in low levels of PA7–9 and that this is associated with
increased mortality10 and hospitalisation.11 The consistent evi-
dence of the effects of PA on COPD exacerbations and mortality has
been rated as moderate, based on longitudinal designs.10 Fewer
studies have examined the associations between SB and health
outcomes.12,13 One study reported a higher mortality risk in people
with COPD who engaged in > 8.5 hours/day of SB independent of
disease severity.12
Recent evidence in the general population has examined the
joint influences of PA and SB, given that people may be sufficiently
physically active but still engage in large amounts of SB. A recent
harmonised meta-analysis examined whether enough PA can
offset the detrimental effects of too much sitting on mortality.14
High levels of moderate intensity exercise of 60 to 75 minutes/day
were shown to eliminate the increased risk of death from high
levels of sitting in a general population of adults.14 Another study
divided adults into one of four activity phenotypes (ie, sufficiently
active with low sedentary time; sufficiently active with high
sedentary time; physically inactive with low sedentary time; and
physically inactive with high sedentary time) to examine
cardiometabolic markers of health.15 That study reported that
adults who were physically active had better cardiometabolic
health than those who were physically inactive, irrespective of
sedentary time. However, no studies have examined the joint
influence of PA and SB on mortality or cardiometabolic risk in
people with COPD. This information would go some way to
examining whether PA and SB are causal factors on these health
outcomes and, thus, may guide the development of interventions
to encourage adequate activity behaviours and help to inform
recommendations about engagement in SB.
The aim of this cohort study was to examine the possible
aetiological associations of four activity phenotypes involving both
PA and recreational screen time with mortality and cardiometa-
bolic risk factors in people with COPD. Recreational screen time
was used as a surrogate marker of leisure-based sitting time. It was
hypothesised that people with COPD who were sufficiently active
and had low recreational screen time would have a lower risk of
mortality and reduced odds of cardiometabolic disease than the
other phenotypes.
Therefore, the research question for this cohort study was:
In people with COPD, are activity phenotypes (involving
physical activity and recreational screen time) associated with
mortality and cardiometabolic risk factors?
Method
Design
A cohort study was conducted with the Scottish Health Survey
2003 providing data at both a national and regional level about the
population living in private households in Scotland. The sample for
this survey was selected using a multi-stage stratified random
sampling procedure based on postcode regions. Further details on
the sampling process have been reported elsewhere.16
Participants
Of eligible adults, 83% consented to take part in the survey. For
this study, participants were included in the analysis if they: were
aged  40 years; were current or ex-smokers; and met the Global
Initiative for Chronic Obstructive Lung Disease (GOLD) spiromet-
ric criteria for severity of airflow limitation (forced expiratory
volume in 1 second (FEV1)/forced vital capacity (FVC) ratio
of < 0.7).17 Participants were followed up to time of death or, if
there was no record of an event, until data were censored on
December 31, 2009.Measurements
Two household visits were conducted to collect survey data: an
interviewer visit for information on socio-economic demo-
graphics, general health and quality of life, followed by a nurse
visit to collect physiological measures. The measurements relevant
to this study are described in more detail below.
Participant characteristics
Interviewers collected basic anthropometric information:
height and weight; ethnic and educational background; informa-
tion on general health; use of health services; and behaviours
affecting health such as eating, drinking, smoking and PA.
Lung function
Spirometry was performed using a calibrated spirometera.
Participants performed at least one practice attempt, followed by
five attempts or until they were deemed too tired to continue. The
best of the five attempts was used as the final result. Further details
of the spirometry protocol have been published elsewhere.18
Exposure variables: physical activity and sitting time
Two domains of PA performed in the 4 weeks before the
interview were assessed: light-intensity (slow/average pace)
and moderate-intensity (fairly brisk/fast pace) walking; and
sport/exercise. For each of these variables, both frequency
(number of days in the previous 4 weeks) and duration (of an
average episode) of participation was reported. Participation in
PA was then calculated in MET-hours/week by multiplying the
volume of activity (frequency  duration) by the intensity of the
activity in METs19 to give a variable of MET-hours/week of
leisure-time PA. This PA variable was converted into two
categories based on adhering to the current PA recommendation
of at least 7.5 MET-hours/week, which is equivalent to
75 minutes/week of vigorous PA or 150 minutes/week of
moderate PA.20 Participants were classified as ‘insufficiently
active’ (< 7.5 MET-hours/week of PA) or ‘sufficiently active’
( 7.5 MET-hours/week of PA).20 A third domain of domestic PA
(eg, general tidying, spring cleaning, heavy manual work,
gardening and ‘do-it-yourself’ activities) was also determined
in the same way as the leisure-based PA to give a variable of
MET-hours/week of domestic PA. This domestic PA variable was
converted into two categories such that participants were
classified as either ‘no domestic PA’ (equal to 0 MET-hours/week
of domestic activity) or ‘some domestic PA’ (> 0 MET-hours/
week of domestic activity). Both variables of leisure-time PA and
domestic PA were used to define the activity phenotypes (see
section on ‘Categories of activity phenotypes’). More details on
the PA interviews can be found in previous reports.21
Recreational screen time was used to determine the amount of
leisure-based sitting behaviour. One question was used to elicit
information about recreational screen time. The question was
asked once in relation to screen time on weekdays and once in
relation to screen time on weekends. The question was: ‘Thinking
of weekdays (or weekend days), how much time on an average day
do you spend watching TV or another type of screen such as a
computer, or video game? Please do not include any time spent in
front of a screen while at school, college or work’. Participants were
classified into two sedentary categories: ‘low leisure-based sitting
time’ ( 200 minutes of recreational screen time/day) and ‘high
leisure-based sitting time’ (> 200 minutes of recreational screen
time/day). A data-driven approach was used for this classification,
where the median level of recreational screen time was deter-
mined as 200 minutes to provide the cut-off values for each
category, given that there is no standard recommendation for what
constitutes high or low levels of recreational screen time for the
COPD population.
Box 1. The four activity phenotypes used in the study and their
definitions.
‘Couch potatoes’  ‘insufficiently active’ with ‘high
leisure-based sitting time’, or
 ‘insufficiently active’ with ‘low
leisure-based sitting time’ and
‘no domestic physical activity’
‘Light movers’  ‘insufficiently active’ with ‘low
leisure-based sitting time’ and
‘some domestic physical activity’
‘Sedentary exercisers’  ‘sufficiently active’ with ‘high
leisure-based sitting time’
‘Busy bees’  ‘sufficiently active’ with ‘low
leisure-based sitting time’
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The PA and sitting time exposures were combined in the
following way to generate the four activity phenotypes, with
labelling based on a previous study,15 as shown in Box 1.
Outcomes: mortality and cardiometabolic variables
All-cause mortality was determined from the Scottish Health
Survey 2003 data, which was linked to the Scottish Information
Division Database with recorded deaths up to December 2009 for
this study. Information on deaths was determined from the
General Registrar Office for Scotland. Classification of the
underlying cause of death was based on information collected
on the death certificate as well as any additional information
provided by the certifying doctor.
The cardiometabolic risk factors that were considered as
outcomes included waist circumference, blood pressure, high-
density lipoprotein (HDL) cholesterol and history of diabetes
(based on self-report, doctor diagnosis or glycated haemoglobin).
The physiological measures were determined from the nurse visit.
For the analysis in this study, these measures were regarded as
normal or abnormal based on the variable cut-offs as defined for
metabolic syndrome.22Waist circumference was determined using
a tape measure at the midpoint between the lower rib and the
upper margin of the iliac crest. Two measures were taken and
recorded to the nearest millimetre. If the two measures differed by
more than 3 cm, a third measure was taken. Waist circumference
measures were then averaged and defined as normal or high (ie,
 102 cm if male or  88 cm if female).
Blood pressure was measured using an electronic
sphygmomanometerb. Three readings were taken at 1-minute
intervals, on the right arm, with the participant seated. The means
of the second and third measures were used in calculations. Blood
pressure was categorised as normal (ie, systolic < 130 mmHg and
diastolic < 85 mmHg, and no self-reported hypertension) or high
(ie, systolic  130 mmHg and diastolic  85 mmHg or self-
reported hypertension).
HDL cholesterol was determined from the non-fasting blood
samples taken during the nurse visit. A chemical analyserc was
used to carry out the HDL cholesterol analysis using a direct
method by the Biochemistry Department at the Royal Victoria
Infirmary in Newcastle upon Tyne, UK. HDL cholesterol was
categorised as normal (ie,  1.03 mmol/l if male or  1.29 mmol/l if
female, and did not take lipid-lowering medication) or abnormal
(ie, < 1.03 mmol/l if male or < 1.29 mmol/l if female, or took lipid-
lowering medication).
Total glycated haemoglobin (HbA1c) was also determined from
the non-fasting blood samples. One of two commercial analysersd,e
was used to carry out the HbA1c analysis by the Haematology
Department at the Royal Victoria Infirmary. Participants were
categorised as having a history of diabetes based on self-report,
doctor diagnosis or a HbA1c  6.5%.Covariates
The following covariates were included in the analyses: age,
gender, severity of COPD (mild, moderate, severe, or very severe
according to the GOLD stages17), history of cardiovascular disease
at baseline, history of cancer at baseline, self-reported longstand-
ing illness, body mass index (BMI), smoking status (current
smoker, ex-smoker, never smoked), age finished full-time educa-
tion ( 14 years, 15 to 18 years, > 19 years), and alcohol consump-
tion (does not drink, less than once a week, one to four times/week,
five or more times/week).
Data analysis
Baseline characteristics across the four activity phenotypes
were examined using chi-square tests for categorical variables and
ANOVA for continuous variables. To determine all-cause mortality
across the four activity phenotypes, Cox proportional hazards
regression models were used to compute hazard ratios (HRs) with
95% confidence intervals (CIs) and survival duration was presented
as mean and 95% CI. The proportional hazards assumption was
examined using the cumulative hazard plot, and no apparent
violations were noted. Covariates were added to the model in three
stages. Model 1 used age and gender. Model 2 used the covariates
from Model 1 plus severity of COPD, history of cardiovascular
disease, history of cancer, self-reported longstanding illness, and
body mass index. Model 3 used the covariates from Model 2 plus
smoking status, age when finished full-time education, and alcohol
consumption. To minimise the possibility of detecting spurious
associations due to underlying/undiagnosed disease (reverse
causality), a sensitivity analysis was also conducted excluding
people who had a mortality event in the first 12 months. Lastly,
binary logistic regression models, adjusted for relevant confoun-
ders (as per Models 1, 2 and 3 above), were used to compute ORs
and 95% CI to examine the association between the four activity
phenotypes and the cardiometabolic outcomes of waist circum-
ference, BP, HDL cholesterol and diabetes history. All analyses were
performed using SPSS softwaref.
Results
A total of 8148 adults completed the Scottish Health Survey
2003 and were potentially eligible for this study. Of this group,
584 met the inclusion criteria (ie, COPD, aged > 40 years and
current or ex-smokers). The variables with the highest number of
missing data were HDL cholesterol (n = 205), blood pressure
(n = 151), mortality (n = 68) and waist circumference (n = 18).
Baseline characteristics of the included group (n = 584) and each of
the four activity phenotypes can be found in Table 1. The greatest
number of participants were categorised as ‘couch potatoes’
(n = 213, 36%). This group was older and had a significantly greater
proportion of people who: had moderate-to-severe lung function;
had a history of cardiovascular disease, diabetes or self-reported
long-standing illness; and finished full-time education at a young
age ( 14 years) (all p < 0.05).
Mortality data were available on 433 participants with COPD
who had complete data on the covariates. A total of 81 all-cause
deaths occurred during the 5.5 years (SD 1.3) of follow-up. Table 2
indicates the HRs and 95% CIs for all-cause mortality. Compared to
the ‘couch potatoes’ there was a reduced risk of all-cause mortality
in the ‘busy bees’ (fully adjusted HR 0.26, 95% CI 0.11 to 0.65) with a
non-significant trend towards a reduction in all-cause mortality in
the ‘sedentary exercisers’ and the ‘light movers’. However, there
was a statistically significant relationship in the reduction in
mortality HR from ‘couch potatoes’ through ‘light movers’, then
‘sedentary exercisers’ and finally ‘busy bees’, with a p-value for
linear trend of 0.005. The sensitivity analysis (ie, excluding people
who had a mortality event in the first 12 months) showed similar
results to the main analysis (data not shown).
Table 2
Association between all-cause mortality and activity phenotype in participants with chronic obstructive pulmonary disease.
Activity phenotypes Survival duration (months) All-cause mortality (n = 433, 81 deaths)
Mean (95% CI) cases/total Model 1
HR (95% CI)
Model 2
HR (95% CI)
Model 3
HR (95% CI)
‘Couch potatoes’ 65.5
(61.9 to 69.0)
48/151 1.00 1.00 1.00
‘Light movers’ 72.9
(70.1 to 75.8)
16/107 0.65
(0.37 to 1.15)
0.74
(0.41 to 1.36)
0.77
(0.42 to 1.4)
‘Sedentary exercisers’ 72.0
(68.3 to 75.7)
11/73 0.56
(0.29 to 1.08)
0.57
(0.28 to 1.15)
0.57
(0.28 to 1.17)
‘Busy bees’ 76.2
(74.1 to 78.2)
6/102 0.22
(0.09 to 0.52)
0.24
(0.10 to 0.60)
0.26
(0.11 to 0.65)
P trend (linear) 0.002 0.003 0.005
Model 1 is adjusted for age and gender.
Model 2 is further adjusted for COPD severity, history of cardiovascular disease, history of cancer, history of diabetes, self-reported longstanding illness and body mass index.
Model 3 is further adjusted for smoking status, age when finished full-time education and alcohol consumption.
Cases/total refers to the number of deaths out of the number of participants in each category.
HR = hazard ratio.
Table 1
Baseline characteristics of 584 participants with chronic obstructive pulmonary disease recruited from the Scottish Health Survey 2003.
Characteristic All participants Activity phenotypes a p
‘Couch potatoes’ ‘Light movers’ ‘Sedentary exercisers’ ‘Busy bees’
Group size, n (%) 584 213 (36%) 138 (24%) 107 (18%) 126 (22%)
Gender, % male 51.7 55.4 40.6 63.6 47.6 0.002
Age (yr), mean (SD) 64 (12) 68 (11) 61 (11) 63 (10) 60 (12) < 0.001
Body mass index (kg/m2), mean (SD) 27 (5) 28 (5) 27 (5) 27 (4) 27 (4) 0.08
Caucasian, % 99.5 99.5 99.3 100 99.2 0.80
GOLD stage of COPD severity, % b < 0.001
I: FEV180% predicted 42.8 32.9 35.4 46.9 61.3
II: 50%  FEV1<80% predicted 31.6 31.7 36.9 36.5 21.8
III: 30%  FEV1<50% predicted 17.6 28.7 14.6 10.4 10.9
IV: FEV1<30% predicted 8.0 6.6 13.1 6.3 5.9
History of cardiovascular disease, % c 19.3 34.7 10.9 13.1 7.9 < 0.001
History of cancer, % 8.2 8.9 4.3 9.3 10.3 0.28
History of diabetes, % d 9.4 16.4 5.8 8.4 2.4 < 0.001
Self-reported longstanding illness, % 60.4 76.1 60.1 53.3 40.5 < 0.001
Self-reported asthma, % 7.9 9.4 8.7 6.5 5.6 0.57
Abnormal waist circumference, % e 42.3 46.9 47.8 41.1 29.4 0.006
High blood pressure, % f 48.1 48.8 50.0 44.9 47.6 0.87
Abnormal HDL cholesterol, % g 24.8 34.3 21.7 19.6 16.7 0.001
Smoking status, % 0.01
current 46.6 46.0 58.0 41.1 39.7
past 53.4 54.0 42.0 58.9 60.3
Age at end of full-time education (yr), % < 0.001
 14 22.3 34.9 14.5 18.7 12.7
15 to 18 65.9 55.7 76.8 68.2 69.0
 19 11.8 9.4 8.7 13.1 18.3
Full-time work, % 74 76 71 76 72 0.7
Alcohol consumed (times/week), % 0.14
0 12.0 15.5 8.0 12.1 10.3
< 1 27.9 29.6 33.3 20.6 25.4
1 to 4 37.3 34.7 36.2 45.8 35.7
 5 22.8 20.2 22.5 21.5 28.6
COPD = chronic obstructive pulmonary disease, FEV1= forced expiratory volume in 1 second; GOLD = global initiative for chronic obstructive lung disease, HDL = high density
lipoprotein.
a Refer to Box 1 for the definition of each activity phenotype.
b COPD severity was classified according to spirometric grades using the GOLD summary.17
c A history of cardiovascular disease was defined as self-reported or doctor-diagnosed angina, heart attack or stroke.
d A history of diabetes was defined as self-reported diabetes or doctor-diagnosed diabetes or glycated haemoglobin (HbA1c)  6.5%.
e Abnormal waist circumference was defined as  102 cm for men and  88 cm for women.
f High blood pressure was defined as  130 mmHg systolic or  85 mmHg diastolic.
g Abnormal high-density lipoprotein (HDL) cholesterol was defined as < 1.03 mmol/l in men and < 1.29 mmol/l in women or specific treatment for lipid abnormality.
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examining the associations between the cardiometabolic risk
factors and the activity phenotypes. In the age-adjusted and
gender-adjusted models, compared to the ‘couch potatoes’
referent group, the odds of a high waist circumference, abnormal
HDL cholesterol and diabetes were lower in the ‘busy bees’; the
odds of abnormal HDL cholesterol and diabetes were lower in the
‘sedentary exercisers’; and the odds of diabetes was lower in the
‘light movers’. In the fully adjusted models, the odds of diabetes
were lower in the ‘busy bees’ compared to the ‘couch potatoes’,
although the overall number of cases in this analysis was small.No other associations were found between the activity pheno-
types and the cardiometabolic markers for the fully adjusted
models.
Discussion
This is the first study in people with COPD to examine the
association of activity phenotypes categorised for both PA and SBs
with mortality and cardiometabolic risk factors. People with COPD
who met current PA recommendations for healthy people by
engaging in  7.5 MET-hours/week of PA and had low leisure-based
Table 3
Associations between high waist circumference, hypertension, abnormal high-density lipoprotein cholesterol and diabetes with activity phenotypes in participants with
chronic obstructive pulmonary disease (n = 491).
Outcome ‘Couch potatoes’ ‘Light movers’ ‘Sedentary exercisers’ ‘Busy bees’ p
cases/total OR
(95% CI)
cases/total OR
(95% CI)
cases/total OR
(95% CI)
cases/total OR
(95% CI)
Waist circumference a 80/167 56/123 35/86 32/115
Model 1 1.00 0.90
(0.55 to 1.46)
0.79
(0.46 to 1.35)
0.43
(0.26 to 0.72)
0.01
Model 2 1.00 1.31
(0.62 to 2.78)
1.40
(0.65 to 3.04)
0.57
(0.25 to 1.31)
0.14
Model 3 1.00 1.33
(0.62 to 2.88)
1.48
(0.68 to 3.26)
0.60
(0.98 to 1.05)
0.16
Blood pressure b 82/167 64/123 39/86 55/115
Model 1 1.00 1.48
(0.90 to 2.44)
1.02
(0.59 to 1.75)
1.28
(0.77 to 2.12)
0.40
Model 2 1.00 1.55
(0.91 to 2.63)
1.12
(0.63 to 1.99)
1.55
(0.89 to 2.70)
0.29
Model 3 1.00 1.46
(0.85 to 2.50)
1.05
(0.59 to 1.88)
1.39
(0.78 to 2.47)
0.46
HDL cholesterol c 57/167 28/123 17/86 20/115
Model 1 1.00 0.61
(0.36 to 1.05)
0.49
(0.26 to 0.91)
0.43
(0.23 to 0.78)
0.02
Model 2 1.00 0.86
(0.47 to 1.58)
0.70
(0.35 to 1.39)
0.66
(0.33 to 1.29)
0.6
Model 3 1.00 0.86
(0.46 to 1.60)
0.77
(0.38 to 1.56)
0.70
(0.35 to 1.41)
0.77
Diabetes d 28/167 7/123 5/86 2/115
Model 1 1.00 0.36
(0.15 to 0.88)
0.32
(0.12 to 0.87)
0.10
(0.02 to 0.44)
0.002
Model 2 1.00 0.38
(0.15 to 0.98)
0.43
(0.15 to 1.23)
0.14
(0.03 to 0.63)
0.02
Model 3 1.00 0.39
(0.15 to 1.03)
0.43
(0.15 to 1.24)
0.14
(0.03 to 0.67)
0.03
Model 1 is adjusted for age and gender.
Model 2 is further adjusted for COPD severity, history of cardiovascular disease, history of cancer, history of diabetes, self-reported longstanding illness and body mass index.
Model 3 is further adjusted for smoking status, age when finished full-time education and alcohol consumption.
Cases/total refers to the number of cases out of the number of participants in each category.
a Abnormal waist circumference was defined  102 cm for men and  88 cm for women.
b High blood pressure was defined as  130 mmHg systolic or  85 mmHg diastolic.
c Abnormal high-density lipoprotein (HDL) cholesterol was defined as < 1.03 mmol/l in men and < 1.29 mmol/l in women or specific treatment for lipid abnormality.
d A history of diabetes was defined as self-reported diabetes or doctor-diagnosed diabetes or glycated haemoglobin (HbA1c)  6.5%.
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(‘busy bees’) had a 74% (95% CI 35 to 89) reduction in all-cause
mortality risk and an 86% (95% CI 33 to 97) reduction in the odds of
diabetes after fully adjusting for covariates compared to those who
were physically inactive and sedentary (‘couch potatoes’). The
statistically significant test for linear trend also suggested some
mortality benefit from being physically active and from having low
sedentary time, even though the comparisons of ‘sedentary
exercisers’ and ‘light movers’ with the ‘couch potatoes’ were non-
significant for mortality.
A recent review examined the studies reporting on the
associations between PA and mortality in people with COPD.10
Of the seven studies included in the review, five studies used
subjective measures to categorise PA into high or low levels, with
reduced risk of mortality (risk ratio ranging from 0.34 to 0.81)
when performing higher levels of PA.11,23–26 However, none of
these studies categorised PA according to current activity
recommendations by considering the volume and intensity of
participation in activity using MET-hours/week as in the current
study. When PA guidelines were met (‘sedentary exercisers’ and
‘busy bees’), there was a reduction in the risk of mortality of
between 43 and 74% compared to the ‘couch potatoes’. Although
this result cannot completely confirm that causation is present (ie,
that not meeting PA guidelines causes death), it indicates that
encouraging people with COPD to meet general PA guidelines may
be important to maximise health outcomes.
Sedentary behaviour in people with COPD has mainly been
examined through sitting time. One review, which included
10 studies measuring sitting time in people with COPD, indicated
a median sitting time of 359 minutes/day.27 Another study of
497 people with COPD specifically reported on time of TVviewing/listening to music and reported this to be 300 minutes/
day.28 In the current study, the median self-reported recreational
screen time was 200 minutes/day and was used as the cut-off to
determine low or high ‘leisure-based sitting time’ as a marker of
SB. People with COPD who had low ‘leisure-based sitting time’
with some domestic PA (‘light movers’) had some mortality
benefit compared to ‘couch potatoes’ but the reduction in
mortality risk was non-significant and smaller (23%) compared
to that seen in people who were sufficiently active. The significant
linear trend across all models (Table 2) indicated a pattern of
smallest to largest risk reduction in all-cause mortality across the
activity phenotypes from ‘light movers’ to ‘sedentary exercisers’
to ‘busy bees’.
Few studies have examined the association between SB and
mortality in COPD. One study examined the association between
average daily TV viewing time and respiratory mortality in a
Japanese population, and reported that men who watched TV for
> 4 hours/day were more likely to die of COPD compared to those
who watched TV for < 2 hours/day (HR 1.63, 95% CI 1.04 to 2.55).13
Another study measured SB objectively and reported that
mortality risk was 4.09 times higher in people with COPD who
spent > 8.5 hours/day in SB of < 1.5 METs.12 The results of the
current study are consistent with these previous findings but
suggest that a combination of meeting PA guidelines and
minimising leisure-based sitting time is required for the greatest
reduction in mortality risk rather than just focusing on interven-
tions to minimise leisure-based sitting time. However, at mini-
mum, if people with COPD are unable to meet PA
recommendations, engagement in some domestic activity and
limiting leisure-based sitting time (as per the ‘light movers’) may
be important.
Research 119The cardiometabolic health profile was not as favourable for the
participants in the ‘couch potato’ group. This group had a
significantly higher proportion of participants with a history of
cardiovascular disease and diabetes compared to the other activity
phenotypes. For the age-adjusted and gender-adjusted models,
when the ‘light movers’, ‘sedentary exercisers’ and ‘busy bees’ were
compared to the ‘couch potatoes’, the odds of diabetes were lower
by between 64 and 90%, and the odds of an abnormal HDL
cholesterol were lower by between 39 and 57%. In the fully
adjusted models, the odds for diabetes were lower in the ‘busy
bees’ compared to the ‘couch potatoes’. One other study of people
with COPD examined the association of PA levels and sedentary
time on metabolic outcomes.29 This study showed that time spent
in light and moderate activity was negatively associated with waist
circumference and glucose level, while sedentary time was
positively associated with these variables.29 These authors
suggested that interventions to reduce SB and promote PA would
be important to minimise metabolic syndrome,29 and this concurs
with the findings from the current study and, furthermore,
suggests that meeting PA guidelines should be the priority
behaviour followed by a reduction in leisure-based sitting time
through reduced recreational screen time.
A strength of this study was its clinical relevance in categorising
participants according to PA recommendations while at the same
time considering levels of SB. However, there were also a number
of limitations. First, the activity phenotypes were created based on
subjective interviews and self-report, rather than using an
objective measure such as accelerometry. We acknowledge that
there may have been some measurement error associated with the
exposures, which would have resulted in attenuation of the
associations. Furthermore, in this study, patterns of accumulation
of physical activity and sedentary behaviour were not able to be
addressed using these subjective measurement tools. Future
studies could consider development of the activity phenotypes
using categories of objectively measured activity, as has been used
previously in English adults.15 Secondly, the categorisation of SB
was based on responses to questions on recreational screen time
rather than specific questions on sitting or lying time. Recreational
screen time does not capture all the leisure-based sitting time that
participants may have been involved in through waking hours, and
excludes other leisure-based sitting activities such as talking on
the phone, reading and other sitting hobbies as well as excluding
work-related screen time and sitting, which are increasing in
workplaces. However, a previous study has shown that survey-
assessed TV viewing time is the strongest correlate to monitor-
assessed total sitting time across the week in non-workers.30
Another study in people with COPD (the majority of whom were
retired) indicated that watching TV is the predominant daily
activity,28 so as a representation of sitting time the questions on
recreational screen time may be a reasonable broad surrogate
measure of SB in this population. Again, an objective measure to
determine sedentary categories could be considered in future
studies. Another limitation was the relatively low number of
participants in each subgroup, which may have compromised
statistical power of some analyses and prevented the ‘sedentary
exercisers’ and ‘light movers’ from being statistically different to
the referent ‘couch potatoes’ despite the clear tendency for an
association in some outcomes. This group was also not an
inception cohort, as they were not people with COPD recruited
at a specific defined point in the course of their disease. A final
limitation was the age of the survey data, which spanned from
2003 to 2009. Any advances in COPD management in the last
decade would not be reflected in the presented data.
This prospective cohort study indicated a mortality benefit and
reduced odds of diabetes for people with COPD who meet PA
guidelines and have low leisure-based sitting time compared to
those who are physically inactive and have high leisure-based
sitting time. These findings suggest that measurement of both PA
levels and SB is important for health outcomes in people with
COPD. Clinicians should encourage adherence to activity recom-mendations foremost for people with COPD, but that if this is not
achievable, ways to minimise SBs should also be considered, such
as through reduced recreational screen time.
What was already known on this topic: People with chronic
obstructive pulmonary disease (COPD) engage in low levels of
physical activity, which is associated with adverse health
effects. Guidelines for people with COPD encourage them to
meet the general physical activity guidelines for adults but
advice about sedentary behaviour is lacking.
What this study adds: Among people with COPD, adhering to
physical activity guidelines and keeping leisure-based sitting
time low has a mortality benefit and lowers the odds of
developing diabetes. Physiotherapists should encourage peo-
ple with COPD to adhere to activity recommendations and also
consider whether sedentary behaviour could be reduced.
Footnotes: a Vitalograph1 Escort, Vitalograph Ltd, London, UK. b
Omron HEM 907, Omron Electronics Ltd, Milton Keynes, UK. c
Olympus 640 analyser, Diamond Diagnostics, Holliston, USA. d
Tosoh HLC-723 A1 c2.2 analyser, Tosoh Europe N. V., Tessenderlo,
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